Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells |
https://doi.org/10.18632/oncotarget.28679 Steven A. Greenberg |
1-8 |
Abstract | PDF | Full Text | How to cite | Press Release |
Retraction: Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model |
https://doi.org/10.18632/oncotarget.28572 Bo Zhang, Dan Wang, Tie-Feng Ji, Lei Shi, and Jin-Lu Yu |
9-9 |
Retraction | PDF | How to cite |
Retraction: Transient activation of the PI3K/Akt pathway promotes Newcastle disease virus replication and enhances anti-apoptotic signaling responses |
https://doi.org/10.18632/oncotarget.28683 Yinfeng Kang, Runyu Yuan, Xiaqiong Zhao, Bin Xiang, Shimin Gao, Pei Gao, Xu Dai, Minsha Feng, Yanling Li, Peng Xie, Yulian Li, Xiaoyi Gao, and Tao Ren |
10-10 |
Retraction | PDF | How to cite |
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms |
https://doi.org/10.18632/oncotarget.28680 Whitney L. Hensing, Emily L. Podany, James J. Sears, Shaili Tapiavala, and Andrew A. Davis |
11-27 |
Abstract | PDF | Full Text | How to cite | Press Release |
Retraction: Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway |
https://doi.org/10.18632/oncotarget.28684 Xuanyang Hu, Zhirong Wang, Jiawei Shi, Xiaobin Guo, Liangliang Wang, Zichuan Ping, Yunxia Tao, Huilin Yang, Jun Zhou, Yaozeng Xu, and Dechun Geng |
28-28 |
Retraction | PDF | How to cite |
Assessment of cfDNA release dynamics during colorectal cancer surgery |
https://doi.org/10.18632/oncotarget.28681 Mailson Alves Lopes, Maria Elvira Ribeiro Cordeiro, Flávio de Alencar Teles Barreto, Lara de Souza Moreno, André Araújo de Medeiros Silva, Mariana Braccialli de Loyola, Mayra Veloso Ayrimoraes Soares, Joao Batista de Sousa, and Fabio Pittella-Silva |
29-38 |
Abstract | PDF | Full Text | How to cite | Press Release |
Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report |
https://doi.org/10.18632/oncotarget.28682 Jenny L. Wu, and Wade T. Iams |
39-42 |
Abstract | PDF | Full Text | How to cite | Press Release |
Retraction: MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression |
https://doi.org/10.18632/oncotarget.28689 Zhe Cheng, Ling-Ling Dai, Xi Wang, Liu-Qun Jia, Xiao-Gang Jing, Peng-Fei Li, Meng Liu, Huan Wang, and Lin An |
43-43 |
Retraction | PDF | How to cite |
A case report of donor cell–derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation |
https://doi.org/10.18632/oncotarget.28686 Aleksandra Mroczkowska-Bękarciak, and Tomasz Wróbel |
44-50 |
Abstract | PDF | Full Text | How to cite | Press Release |
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types |
https://doi.org/10.18632/oncotarget.28688 Elodie Verdier, Nathalie Gaspar, Maria Eugenia Marques Da Costa, and Antonin Marchais |
51-62 |
Abstract | PDF | Full Text | How to cite | Press Release |
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression |
https://doi.org/10.18632/oncotarget.28692 Haolong Li, Ning Xie, Martin E. Gleave, and Xuesen Dong |
63-64 |
Correction | PDF | How to cite |
Correction: Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass |
https://doi.org/10.18632/oncotarget.28693 Chih-Cheng Yang, Ladan Fazli, Salvatore Loguercio, Irina Zharkikh, Pedro Aza-Blanc, Martin E. Gleave, and Dieter A. Wolf |
65-66 |
Correction | PDF | How to cite |
Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen |
https://doi.org/10.18632/oncotarget.28687 Doaa A. Gamal, Aiat Morsy, and Mervat Omar |
67-78 |
Abstract | PDF | Full Text | How to cite | Press Release |
Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells |
https://doi.org/10.18632/oncotarget.28690 Jessica J. Miciak, Lucy Petrova, Rhythm Sajwan, Aditya Pandya, Mikayla Deckard, Andrew J. Munoz, and Fred Bunz |
79-100 |
Abstract | PDF | Full Text | How to cite | Press Release |
Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.28694 Zhikui Liu, Changwei Dou, Bowen Yao, Meng Xu, Linglong Ding, Yufeng Wang, Yuli Jia, Qing Li, Hongyong Zhang, Kangsheng Tu, Tao Song, and Qingguang Liu |
101-101 |
Retraction | PDF | How to cite |
Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.28695 Zhikui Liu, Changwei Dou, Bowen Yao, Meng Xu, Linglong Ding, Yufeng Wang, Yuli Jia, Qing Li, Hongyong Zhang, Kangsheng Tu, Tao Song, and Qingguang Liu |
102-102 |
Retraction | PDF | How to cite |
Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters’ model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane |
https://doi.org/10.18632/oncotarget.28685 Ana Chor, Hélio dos Santos Dutra, Marcos Lopes Dias, Raquel Pires Gonçalves, Alexandre Malta Rossi, Christina Maeda Takiya, and Marcos Farina |
103-117 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells |
https://doi.org/10.18632/oncotarget.28691 Elham Taheri, and Maryam Raeeszadeh-Sarmazdeh |
118-130 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Retraction: FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome |
https://doi.org/10.18632/oncotarget.28697 Zhongming Huang, Junhua Li, Shaohua Du, Yanghua Tang, Ligang Huang, Luwei Xiao, and Peijian Tong |
131-131 |
Retraction | PDF | How to cite |
Addendum: Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue |
https://doi.org/10.18632/oncotarget.28699 Jyoti Roy, Karson S. Putt, Domenico Coppola, Marino E. Leon, Farah K. Khalil, Barbara A. Centeno, Noel Clark, Valerie E. Stark, David L. Morse, and Philip S. Low |
132-132 |
Addendum | PDF | Supplementary Information | How to cite |
EXPOSOMES and GENES: The duo influencing CANCER initiation and progression |
https://doi.org/10.18632/oncotarget.28696 Uzma Saqib, Katherine E. Ricks, Alexander G. Obukhov, and Krishnan Hajela |
133-135 |
PDF | How to cite | Press Release |
Retraction: MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process |
https://doi.org/10.18632/oncotarget.28702 Youmao Tao, Songbai Yang, Yuanyu Wu, Xuedong Fang, Yannan Wang, Yan Song, and Tao Han |
136-137 |
Retraction | PDF | How to cite |
COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE |
https://doi.org/10.18632/oncotarget.28698 Mangesh A. Thorat |
138-139 |
PDF | How to cite | Press Release |
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients |
https://doi.org/10.18632/oncotarget.28703 Wafik S. El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A. Carneiro, Don S. Dizon, Jeremy L. Warner, Stephanie L. Graff, Christopher G. Azzoli, Eric T. Wong, Liang Cheng, Sendurai A. Mani, Howard P. Safran, Casey Williams, Tobias Meissner, Benjamin Solomon, Eitan Rubin, Angel Porgador, Guy Berchem, Pierre Saintigny, Amir Onn, Jair Bar, Raanan Berger, Manon Gantenbein, Zhen Chen, Cristiano de Pádua Souza, Rui Manuel Vieira Reis, Marina Sekacheva, Andrés Cervantes, William L. Dahut, Christina M. Annunziata, Kerri Gober, Khaled M. Musallam, Humaid O. Al-Shamsi, Ibrahim Abu-Gheida, Ramon Salazar, Sewanti Limaye, Adel T. Aref, Roger R. Reddel, Mohammed Ussama Al Homsi, Abdul Rouf, Said Dermime, Jassim Al Suwaidi, Catalin Vlad, Rares Buiga, Amal Al Omari, Hikmat Abdel-Razeq, Luis F. Oñate-Ocaña, Finn Cilius Nielsen, Leah Graham, Jens Rueter, Anthony M. Joshua, Eugenia Girda, Steven Libutti, Gregory Riedlinger, Mohammed E. Salem, Carol J. Farhangfar, Ruben A. Mesa, Bishoy M. Faltas, Olivier Elemento, C.S. Pramesh, Manju Sengar, Satoru Aoyama, Sadakatsu Ikeda, Ioana Berindan-Neagoe, Himabindu Gaddipati, Mandar Kulkarni, Elisabeth Auzias, Maria Gerogianni, Nicolas Wolikow, Simon Istolainen, Pessie Schlafrig, Naftali Z. Frankel, Amanda R. Ferraro, Jim Palma, Alejandro Piris Gimenez, Alberto Hernando-Calvo, Enriqueta Felip, Apostolia M. Tsimberidou, Roy S. Herbst, Josep Tabernero, Richard L. Schilsky, Jia Liu, Yves Lussier, Jacques Raynaud, Gerald Batist, Shai Magidi, and Razelle Kurzrock |
140-162 |
Abstract | PDF | Full Text | How to cite | Press Release |
No disease left behind |
https://doi.org/10.18632/oncotarget.28700 Muzamil Arshad, Connor Lynch, Rohan R. Katipally, Sean P. Pitroda, and Ralph R. Weichselbaum |
163-166 |
PDF | How to cite | Press Release |
Retraction: Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1 |
https://doi.org/10.18632/oncotarget.28704 Chun-Li Song, Bin Liu, Hong-Ying Diao, Yong-Feng Shi, Ji-Chang Zhang, Yang-Xue Li, Ning Liu, Yun-Peng Yu, Guan Wang, Jin-Peng Wang, and Qian Li |
167-167 |
Retraction | PDF | How to cite |
Signaling pathway dysregulation in breast cancer |
https://doi.org/10.18632/oncotarget.28701 Dinara Ryspayeva, Attila A. Seyhan, William J. MacDonald, Connor Purcell, Tyler J. Roady, Maryam Ghandali, Nataliia Verovkina, Wafik S. El-Deiry, Martin S. Taylor, and Stephanie L. Graff |
168-201 |
Abstract | PDF | Full Text | How to cite | Press Release |
FGR Src family kinase causes signaling and phenotypic shift mimicking retinoic acid-induced differentiation of leukemic cells |
https://doi.org/10.18632/oncotarget.28705 Noor Kazim, Wang Peng, Jianbo Yue, and Andrew Yen |
202-218 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Retraction: Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer |
https://doi.org/10.18632/oncotarget.28708 Fei Song, Geng Wang, Zhifang Ma, Yuebing Ma, and Yingying Wang |
219-219 |
Retraction | PDF | How to cite |
NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma |
https://doi.org/10.18632/oncotarget.28706 Andrea Gunnell, Scott T. Kimber, Richard Houlston, and Martin Kaiser |
220-229 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT |
https://doi.org/10.18632/oncotarget.28707 Lanlan Zhou, Leiqing Zhang, Jun Zhang, Laura Jinxuan Wu, Shengliang Zhang, Andrew George, Marina Hahn, Howard P. Safran, Clark C. Chen, Attila A. Seyhan, Eric T. Wong, and Wafik S. El-Deiry |
230-248 |
Abstract | PDF | Full Text | Supplementary Information | How to cite |
Copyright © 2025 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC